Studies on complications and prognosis in blood circulation reconstruction

Studies on complications and prognosis in blood circulation reconstruction

Ischemic cerebrovascular disorder is a major disease of stroke. Secondary prevention is an important theme because neurological symptoms due to ischemic cerebrovascular disorders reduce ADL and limit the social activities of patients.
Ischemic cerebrovascular disorders include (1) in the carotid artery stenosis in the carotid artery in the carotid artery in the carotid artery in the carotid artery stenosis in the carotid in the carotid in the carotid artery stenosis (2) in the carotid artery stenosis in the carotid in the carotid in the carotid, (2) in the carotid in the carotid in the carotid in the carotid in the carotid in the carotid in the carotid in the carotid in the carotid in the carotid in the carotid in the carotid in the carotid in the carotid in the carotid in the carotid in the carotid in the car
At the same time, intravascular and surgical treatments for secondary prevention of symptomatic main arterial lesions have been found to be useful in large-scale clinical trials. Internal carotid artery thrombotic peritoneal exfoliation (CEA), carotid artery stent placement (CAS), percutaneous vascular formation (PTA), and extracranial vascular anastomosis (pass) are among the options for hematology reconstruction. Peroperative ischemic complications and overreturn syndrome associated with changes in the incranial blood flow have been reported as complications, and it has been pointed out that postoperative functional prognosis may be worsened.
The purpose of this study is to find a treatment strategy that reduces perioperative complications by examining perioperative complications and postoperative prognosis in patients with main arterial lesions that have undergone blood reconstruction.

This is an observational study to examine lesions, blood circulation reconstruction, perioperative laboratory findings, perioperative complications, and postoperative prognosis for patients with main arterial lesions whose hematology has been performed at the Yokohama City Stroke Neurospinal Center.

Patients with main arterial lesions that have undergone blood reconstruction (from January 1, 2021 to December 31, 2025)

From June 11, 2021 to December 31, 2027

We collect information on disease name, age, gender, treatment details, treatment outcomes, and postoperative long-term prognosis from existing medical record information.

Samples and information will be strictly controlled for a period of at least five years from the end date of this study or three years from the date of reporting the final publication of the results of this study, whichever is later. When storing the correspondence table and other personal information in electronic data, the password is stored on an independent computer device that is not connected to the in-hospital LAN or the Internet, and when stored on paper, it is strictly managed in a bookshelf that can be bound to a file and locked, and stored so that anyone other than researchers involved in this study cannot access it.
In addition, the information stored in electronic media after the research is completed will be erased in a form that cannot be restored from the stored computer terminal, etc., and the information stored in paper media will be promptly disposed of by shredder.

Shigeta Miyake, Yokohama City Apolexy and Spinal Nerves Center Neurosurgery

Since this study is limited to observational studies using existing information, it is unlikely that there will be no health damage to patients associated with this study. Therefore, there is no physical risk associated with participating in this study. At the same time, there is no profit.

If you have any questions or concerns about this research, please contact the following address.
If you wish, you can browse the research plan and related materials within a range that does not interfere with the protection of personal information and intellectual property of other research subjects, so please contact us by telephone or fax.
In addition, if the patient or the patient's proxy/agent does not understand that the sample or information is used in the research, it will not be included in the research. Please contact the following address. In that case, there will be no disadvantage to the patient.

〒235-0012 1-2-1, Takigashira, Isogo-ku, Yokohama-shi, Kanagawa
Yokohama City Apolexy and Spinal Nerves Center Neurosurgery
Shigeta Miyake
TEL: 045-753-2500 (Representative) FAX: 045-753-2859